Ever Source Wealth Advisors, LLC Crinetics Pharmaceuticals, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.66 Billion
- Q1 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 71 shares of CRNX stock, worth $2,291. This represents 0.0% of its overall portfolio holdings.
Number of Shares
71
Previous 87
18.39%
Holding current value
$2,291
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CRNX
# of Institutions
235Shares Held
87MCall Options Held
40KPut Options Held
162K-
Vanguard Group Inc Valley Forge, PA9.31MShares$301 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.89MShares$222 Million0.05% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.24MShares$201 Million2.28% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$201 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.11MShares$165 Million0.02% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $1.74B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...